VEJA TAMBÉM
HLA Anticorpos
Empty Table Header | Nome do Produto | CATALOG # | Isótopo | Epitopo | Aplicacao | Species | Uso e aplicacao | NOTAS |
---|---|---|---|---|---|---|---|---|
HLA class I Anticorpo (HP-1F7) | sc-69892 | mouse IgG1 κ | (h) | WB, IP, FCM | h | 7 | ||
HLA class I Anticorpo (YTH862.2) | sc-59206 | rat IgG2b | (h) | WB, IP, IF, FCM | h | 2 | ||
HLA class I Anticorpo (MEM-147) | sc-51672 | mouse IgG1 | (h) | WB (non-reducing), IP, FCM | h | new | ||
HLA-A Anticorpo (B-11) | sc-390473 | mouse IgM κ | 26-45 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 3 | ||
HLA-A Anticorpo (C-6) | sc-365485 | mouse IgG2b κ | 61-93 (h) | WB, IP, IF, IHC(P), ELISA | h | 9 | ||
HLA-A/B/C Anticorpo (LY5.1) | sc-52810 | mouse IgG1 κ | (h) | WB, IP, IF | h | 8 | ||
HLA-A/B/C Anticorpo (3F10) | sc-65288 | mouse IgG2a | (h) | IP, IF, FCM | h | 1 | ||
HLA-A2 Anticorpo (BB7.2) | sc-32236 | mouse IgG2b κ | (h) | FCM | h | 12 | ||
HLA-B/C Anticorpo (A-3) | sc-166668 | mouse IgG1 κ | 126-145 (h) | WB, IP, IF, ELISA | m, r, h | 1 | ||
HLA-B/C Anticorpo (A-4) | sc-166544 | mouse IgG2a κ | N-terminal (h) | WB, IP, IF, ELISA | h | new | ||
HLA-B7 Anticorpo (BB7.1) | sc-53304 | mouse IgG1 κ | (h) | FCM | h | 2 | ||
HLA-B27 Anticorpo (EP-4) | sc-59233 | mouse IgM | (h) | IF | h | new | ||
HLA-C Anticorpo (H-5) | sc-166134 | mouse IgG3 κ | 91-123 (h) | WB, IP, IF, IHC(P), ELISA | h | 1 | ||
HLA-C Anticorpo (C-8) | sc-166088 | mouse IgG1 κ | 91-123 (h) | WB, IP, IF, ELISA | h | 2 | ||
HLA-C Anticorpo (D-9) | sc-166057 | mouse IgG1 κ | 91-123 (h) | WB, IP, IF, ELISA | h | new | ||
HLA-D/DR/DQ Anticorpo (35) | sc-53305 | mouse IgG3 κ | (m) | IP, IF, FCM | h | 1 | ||
HLA-DM Anticorpo (MaP.DM1) | sc-32248 | mouse IgG1 κ | (h) | IF, FCM | h | 5 | ||
HLA-DMα Anticorpo (NB-B33) | sc-134356 | mouse IgG1 κ | 1-262 (h) | WB, IP, IF, IHC(P), ELISA | h | 1 | ||
HLA-DMβ Anticorpo (E-8) | sc-393548 | mouse IgG1 κ | FL (h) | WB, IP, IF, IHC(P), ELISA | h | 1 | ||
HLA-DMβ Anticorpo (DM.K8) | sc-69738 | mouse IgG1 κ | (h) | WB, IP, IF | h | new | ||
HLA-DOα Anticorpo (C-11) | sc-515446 | mouse IgG1 κ | 83-127 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
HLA-DOβ Anticorpo (DOB.L1) | sc-69739 | mouse IgG2b κ | (h) | WB, IP, IF, IHC(P) | h | 3 | ||
HLA-DP Anticorpo (G-9) | sc-390694 | mouse IgG2b κ | 69-102 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
HLA-DP Anticorpo (BRAFB6) | sc-33719 | mouse IgG2b κ | FL (h) | WB, IP, FCM | m, r, h | 6 | ||
HLA-DP Anticorpo (OX76) | sc-53077 | mouse IgG2a κ | (r) | FCM | m, r | new | ||
HLA-DP Anticorpo (DP 11.1) | sc-53308 | mouse IgG2a κ | (h) | WB, IP, IF, IHC(P), FCM | h | 4 | ||
HLA-DP β1 Anticorpo (7-RE35) | sc-134357 | mouse IgG2a κ | 1-259 (h) | WB, IP, IF, IHC(P), ELISA | h | 1 | ||
HLA-DP/DR/DQ Anticorpo (PdV5.2) | sc-130013 | mouse IgG1 κ | (h) | WB, IP, IF, IHC(P), functional assay | h | 2 | ||
HLA-DP/DR/DQ Anticorpo (7.5.10.1) | sc-59238 | mouse IgG2a κ | (h) | IF | h and canine | new | ||
HLA-DPα1 Anticorpo (NB-A3) | sc-134358 | mouse IgG2a κ | 1-261 (h) | WB, IP, ELISA | h | 1 | ||
HLA-DQ Anticorpo (TAL 4.1) | sc-53312 | mouse IgG2b κ | (h) | WB, IF, FCM | h | 1 | ||
HLA-DQ Anticorpo (B-K27) | sc-65320 | mouse IgG2a | (h) | IP, FCM | h | new | ||
HLA-DQ Anticorpo (HLADQ1) | sc-73390 | mouse IgG1 | (h) | IF, IHC(P), FCM | h | new | ||
HLA-DQ1/3 Anticorpo (HL-37) | sc-51615 | mouse IgG3 | (h) | WB (non-reducing), IP, FCM | h | new | ||
HLA-DQ3 Anticorpo (2HB6) | sc-53310 | mouse IgG1 κ | (h) | IP, FCM | m | new | ||
HLA-DQ3/DQ4/DR4 Anticorpo (TAL 12.1) | sc-53311 | mouse IgG2b κ | (h) | WB, FCM | h | new | ||
HLA-DQB1 Anticorpo (Genox 3.53) | sc-53313 | mouse IgG1 κ | (h) | WB, IP, IF, FCM | h | new | ||
HLA-DQB1 Anticorpo (IIB3) | sc-59247 | mouse IgG2b κ | IF | h | new | |||
HLA-DR Anticorpo (520B) | sc-69673 | mouse IgG2b κ | (h) | WB, IP, IF, IHC(P), FCM | h | 2 | ||
HLA-DR Anticorpo (TAL 1B5) | sc-53319 | mouse IgG1 κ | (h) | WB, IP, IF, IHC(P) | m, r, h | 34 | ||
HLA-DR Anticorpo (Bra22) | sc-33718 | mouse IgG1 κ | FL (h) | WB, IP, IF, IHC(P), FCM | m, r, h | 6 | ||
HLA-DR Anticorpo (L243) | sc-18875 | mouse IgG2a κ | (h) | IF, IHC(P), FCM | h | 17 | ||
HLA-DR Anticorpo (2.06) | sc-53517 | mouse IgG1 κ | (h) | WB, IP | m, r, h | 1 | ||
HLA-DR Anticorpo (ML11C11) | sc-73366 | mouse IgG1 κ | (h) | WB, IP, IF, FCM | h | 1 | ||
HLA-DR Anticorpo (6A96) | sc-71260 | mouse IgG2b κ | (h) | WB, IP, FCM | m, r, h | new | ||
HLA-DR Anticorpo (Bra20) | sc-33720 | mouse IgG2b κ | FL (h) | WB, IP, FCM | m, r, h | new | ||
HLA-DR Anticorpo (Bra30) | sc-33717 | mouse IgG2a κ | (h) | WB, IP, FCM | m, r, h | new | ||
HLA-DR Anticorpo (LN3) | sc-59252 | mouse IgG2b κ | (h) | WB, IP, FCM | h | new | ||
HLA-DR Anticorpo (SPM289) | sc-56545 | mouse IgG2b κ | (h) | WB, IP, IF, IHC(P), FCM | m, r, h | new | ||
HLA-DR Anticorpo (TAL 15.1) | sc-53317 | mouse IgG2a κ | (h) | WB, IP, FCM | h | new | ||
HLA-DR/DP Anticorpo (HL-40) | sc-51617 | mouse IgG2a | (h) | WB, IP, FCM | h | 5 | ||
HLA-DR/DP Anticorpo (HL-38) | sc-51616 | mouse IgG2a | (h) | WB (non-reducing), IP, FCM | h | new | ||
HLA-DR/DP Anticorpo (MEM-136) | sc-51618 | mouse IgG1 | (h) | WB, IP, FCM | h | 3 | ||
HLA-DR/DP/DQ/DX Anticorpo (CR3/43) | sc-53302 | mouse IgG1 κ | (h) | WB, IP, IF, IHC(P) | h | 13 | ||
HLA-DRα Anticorpo (G-7) | sc-55593 | mouse IgG1 κ | FL (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 9 | ||
HLA-DRα Anticorpo (DA6.147) | sc-53499 | mouse IgG1 κ | (h) | WB, IP, IF | m, r, h | 4 | ||
HLA-DRα Anticorpo (B-10) | sc-55592 | mouse IgG1 κ | FL (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | new | ||
HLA-DRβ Anticorpo (DA2) | sc-53314 | mouse IgG1 κ | (h) | WB, IP, IF, FCM | h | 3 | ||
HLA-DRβ Anticorpo (HB10A) | sc-73654 | mouse IgG2a κ | (h) | WB, IP, IF, IHC(P) | h | 1 | ||
HLA-DRβ Anticorpo (TAL 14.1) | sc-53316 | mouse IgG2a κ | (h) | WB, IP, IF, IHC(P), FCM | h | 2 | ||
HLA-DRβ Anticorpo (TDR 31.1) | sc-53321 | mouse IgG1 κ | (h) | WB, IP, FCM | h | new | ||
HLA-DRβ Anticorpo (7.3.19.1) | sc-59261 | mouse IgG2b κ | FL (h) | IF | h | new | ||
HLA-DRβ5 Anticorpo (4D12) | sc-53889 | mouse IgG1 κ | (h) | WB, IP | h | new | ||
HLA-E Anticorpo (3H2679) | sc-71262 | mouse IgG1 κ | (h) | WB, IP, IF, IHC(P) | h | 3 | ||
HLA-E Anticorpo (MEM-E/02) | sc-51621 | mouse IgG1 | (h) | WB, IP, IF, IHC(P) | h | 7 | ||
HLA-E Anticorpo (MEM-E/06) | sc-51622 | mouse IgG1 | (h) | WB, IP, IF, IHC(P), FCM | h | 3 | ||
HLA-E Anticorpo (MEM-E/08) | sc-51624 | mouse IgG1 | (h) | WB, IP, FCM | h | 2 | ||
HLA-E Anticorpo (4D12) | sc-517455 | mouse IgG1 κ | (h) | WB, IP, IF, FCM | h | new | ||
HLA-F Anticorpo (201A2H) | sc-517640 | mouse IgG1 κ | (h) | WB | h | new | ||
HLA-F Anticorpo (201A2J) | sc-517641 | mouse IgG1 κ | (h) | WB | h | new | ||
HLA-G Anticorpo (4H84) | sc-21799 | mouse IgG1 κ | 61-83 (h) | WB, IP, IF, IHC(P) | m, r, h | 83 | ||
HLA-G Anticorpo (MEM-G/9) | sc-51678 | mouse IgG1 | (h) | WB, IP, IF, FCM | h | 7 | ||
HLA-G Anticorpo (MEM-G/1) | sc-51674 | mouse IgG1 | (h) | WB, IP, IF, IHC(P) | h | 6 | ||
HLA-G Anticorpo (MEM-G/2) | sc-51676 | mouse IgG1 | (h) | WB, IP, IF, IHC(P) | h | 2 | ||
HLA-G Anticorpo (6D463) | sc-71263 | mouse IgG1 | (h) | WB, IP, IF, IHC(P) | h | new | ||
HLA-G Anticorpo (9-1F10) | sc-53825 | mouse IgG1 | (h) | WB, IP, IF, FCM | h | 1 |
HLA CRISPR Knockout, HDR and Double Nickase Plasmids
Empty Table Header | Nome do Produto | CATALOG # | Species | Aplicacao | MARCADOR | Uso e aplicacao | NOTAS |
---|---|---|---|---|---|---|---|
HLA-A Plasmídeo CRISPR/Cas9 KO (h) | sc-400294 | h | Gene Knockout | GFP | 0 | ||
HLA-APlasmídeo HDR (h) | sc-400294-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-A Plasmídeo duplo de Nickase (h) | sc-400294-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-A Plasmídeo duplo de Nickase (h2) | sc-400294-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-B Plasmídeo CRISPR/Cas9 KO (h) | sc-400627 | h | Gene Knockout | GFP | 0 | ||
HLA-BPlasmídeo HDR (h) | sc-400627-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-B Plasmídeo duplo de Nickase (h) | sc-400627-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-B Plasmídeo duplo de Nickase (h2) | sc-400627-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-C Plasmídeo CRISPR/Cas9 KO (h) | sc-401517 | h | Gene Knockout | GFP | 0 | ||
HLA-CPlasmídeo HDR (h) | sc-401517-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-C Plasmídeo duplo de Nickase (h) | sc-401517-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-C Plasmídeo duplo de Nickase (h2) | sc-401517-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DMα Plasmídeo CRISPR/Cas9 KO (h) | sc-404576 | h | Gene Knockout | GFP | 0 | ||
HLA-DMαPlasmídeo HDR (h) | sc-404576-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-DMα Plasmídeo duplo de Nickase (h) | sc-404576-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DMα Plasmídeo duplo de Nickase (h2) | sc-404576-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DMα Plasmídeo CRISPR/Cas9 KO (m) | sc-420769 | m | Gene Knockout | GFP | 0 | ||
HLA-DMαPlasmídeo HDR (m) | sc-420769-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
HLA-DMα Plasmídeo duplo de Nickase (m) | sc-420769-NIC | m | Gene Knockout | Puromycin | 0 | ||
HLA-DMα Plasmídeo duplo de Nickase (m2) | sc-420769-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
HLA-DMβ Plasmídeo CRISPR/Cas9 KO (h) | sc-406436 | h | Gene Knockout | GFP | 0 | ||
HLA-DMβPlasmídeo HDR (h2) | sc-406436-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-DMβ Plasmídeo duplo de Nickase (h) | sc-406436-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DMβ Plasmídeo duplo de Nickase (h2) | sc-406436-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DMβ Plasmídeo CRISPR/Cas9 KO (m) | sc-420770 | m | Gene Knockout | GFP | 0 | ||
HLA-DMβPlasmídeo HDR (m) | sc-420770-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
HLA-DMβ Plasmídeo duplo de Nickase (m) | sc-420770-NIC | m | Gene Knockout | Puromycin | 0 | ||
HLA-DMβ Plasmídeo duplo de Nickase (m2) | sc-420770-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
HLA-DOα Plasmídeo CRISPR/Cas9 KO (h) | sc-410820 | h | Gene Knockout | GFP | 0 | ||
HLA-DOαPlasmídeo HDR (h) | sc-410820-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-DOα Plasmídeo duplo de Nickase (h) | sc-410820-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DOα Plasmídeo duplo de Nickase (h2) | sc-410820-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DOα Plasmídeo CRISPR/Cas9 KO (m) | sc-420772 | m | Gene Knockout | GFP | 0 | ||
HLA-DOαPlasmídeo HDR (m) | sc-420772-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
HLA-DOα Plasmídeo duplo de Nickase (m) | sc-420772-NIC | m | Gene Knockout | Puromycin | 0 | ||
HLA-DOα Plasmídeo duplo de Nickase (m2) | sc-420772-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
HLA-DOβ Plasmídeo CRISPR/Cas9 KO (h) | sc-406402 | h | Gene Knockout | GFP | 0 | ||
HLA-DOβPlasmídeo HDR (h) | sc-406402-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-DOβ Plasmídeo duplo de Nickase (h) | sc-406402-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DOβ Plasmídeo duplo de Nickase (h2) | sc-406402-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DOβ Plasmídeo CRISPR/Cas9 KO (m) | sc-420773 | m | Gene Knockout | GFP | 0 | ||
HLA-DOβPlasmídeo HDR (m) | sc-420773-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
HLA-DOβ Plasmídeo duplo de Nickase (m) | sc-420773-NIC | m | Gene Knockout | Puromycin | 0 | ||
HLA-DOβ Plasmídeo duplo de Nickase (m2) | sc-420773-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
HLA-DRα Plasmídeo CRISPR/Cas9 KO (h2) | sc-401010-KO-2 | h | Gene Knockout | GFP | 0 | ||
HLA-DRαPlasmídeo HDR (h2) | sc-401010-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-DRα Plasmídeo duplo de Nickase (h) | sc-401010-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DRα Plasmídeo duplo de Nickase (h2) | sc-401010-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-E Plasmídeo CRISPR/Cas9 KO (h2) | sc-403124-KO-2 | h | Gene Knockout | GFP | 0 | ||
HLA-EPlasmídeo HDR (h2) | sc-403124-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-E Plasmídeo duplo de Nickase (h) | sc-403124-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-E Plasmídeo duplo de Nickase (h2) | sc-403124-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-E Plasmídeo CRISPR/Cas9 KO (m) | sc-437133 | m | Gene Knockout | GFP | 0 | ||
HLA-EPlasmídeo HDR (m) | sc-437133-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
HLA-E Plasmídeo duplo de Nickase (m) | sc-437133-NIC | m | Gene Knockout | Puromycin | 0 | ||
HLA-E Plasmídeo duplo de Nickase (m2) | sc-437133-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
HLA-F Plasmídeo CRISPR/Cas9 KO (h) | sc-410821 | h | Gene Knockout | GFP | 0 | ||
HLA-F Plasmídeo duplo de Nickase (h) | sc-410821-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-F Plasmídeo duplo de Nickase (h2) | sc-410821-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-G Plasmídeo CRISPR/Cas9 KO (h2) | sc-401226-KO-2 | h | Gene Knockout | GFP | 0 | ||
HLA-GPlasmídeo HDR (h2) | sc-401226-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-G Plasmídeo duplo de Nickase (h) | sc-401226-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-G Plasmídeo duplo de Nickase (h2) | sc-401226-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-G Plasmídeo CRISPR/Cas9 KO (m) | sc-420761 | m | Gene Knockout | GFP | 0 | ||
HLA-GPlasmídeo HDR (m) | sc-420761-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
HLA-G Plasmídeo duplo de Nickase (m) | sc-420761-NIC | m | Gene Knockout | Puromycin | 0 | ||
HLA-G Plasmídeo duplo de Nickase (m2) | sc-420761-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
HLA-DP β1 Plasmídeo CRISPR/Cas9 KO (h) | sc-401413 | h | Gene Knockout | GFP | 0 | ||
HLA-DP β1Plasmídeo HDR (h) | sc-401413-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-DP β1 Plasmídeo duplo de Nickase (h) | sc-401413-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DP β1 Plasmídeo duplo de Nickase (h2) | sc-401413-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DPα1 Plasmídeo CRISPR/Cas9 KO (h) | sc-417402 | h | Gene Knockout | GFP | 0 | ||
HLA-DPα1Plasmídeo HDR (h) | sc-417402-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-DPα1 Plasmídeo duplo de Nickase (h) | sc-417402-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DPα1 Plasmídeo duplo de Nickase (h2) | sc-417402-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DQA1 Plasmídeo CRISPR/Cas9 KO (h) | sc-403480 | h | Gene Knockout | GFP | 0 | ||
HLA-DQA1Plasmídeo HDR (h) | sc-403480-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-DQA1 Plasmídeo duplo de Nickase (h) | sc-403480-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DQA1 Plasmídeo duplo de Nickase (h2) | sc-403480-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DQB1 Plasmídeo CRISPR/Cas9 KO (h2) | sc-403051-KO-2 | h | Gene Knockout | GFP | 0 | ||
HLA-DQB1 Plasmídeo duplo de Nickase (h) | sc-403051-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DQB1 Plasmídeo duplo de Nickase (h2) | sc-403051-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DRβ1 Plasmídeo CRISPR/Cas9 KO (h) | sc-406727 | h | Gene Knockout | GFP | 0 | ||
HLA-DRβ1 Plasmídeo CRISPR/Cas9 KO (h2) | sc-406727-KO-2 | h2 | Gene Knockout | GFP | 0 | ||
HLA-DRβ1Plasmídeo HDR (h2) | sc-406727-HDR-2 | h2 | Homology Directed Repair | Puromycin | 0 | ||
HLA-DRβ1 Plasmídeo duplo de Nickase (h) | sc-406727-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DRβ1 Plasmídeo duplo de Nickase (h2) | sc-406727-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-HB1 Plasmídeo CRISPR/Cas9 KO (h) | sc-412897 | h | Gene Knockout | GFP | 0 | ||
HLA-HB1Plasmídeo HDR (h) | sc-412897-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-HB1 Plasmídeo duplo de Nickase (h) | sc-412897-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-HB1 Plasmídeo duplo de Nickase (h2) | sc-412897-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DMβ2 Plasmídeo CRISPR/Cas9 KO (m) | sc-420771 | m | Gene Knockout | GFP | 0 | ||
HLA-DMβ2Plasmídeo HDR (m) | sc-420771-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
HLA-DMβ2 Plasmídeo duplo de Nickase (m) | sc-420771-NIC | m | Gene Knockout | Puromycin | 0 | ||
HLA-DMβ2 Plasmídeo duplo de Nickase (m2) | sc-420771-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
HLA-DQA2 Plasmídeo CRISPR/Cas9 KO (h) | sc-408740 | h | Gene Knockout | GFP | 0 | ||
HLA-DQA2Plasmídeo HDR (h) | sc-408740-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-DQA2 Plasmídeo duplo de Nickase (h) | sc-408740-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DQA2 Plasmídeo duplo de Nickase (h2) | sc-408740-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DQB2 Plasmídeo CRISPR/Cas9 KO (h) | sc-418865 | h | Gene Knockout | GFP | 0 | ||
HLA-DQB2Plasmídeo HDR (h) | sc-418865-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-DQB2 Plasmídeo duplo de Nickase (h) | sc-418865-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DQB2 Plasmídeo duplo de Nickase (h2) | sc-418865-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DRβ5 Plasmídeo CRISPR/Cas9 KO (h) | sc-402985 | h | Gene Knockout | GFP | 0 | ||
HLA-DRβ5Plasmídeo HDR (h) | sc-402985-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-DRβ5 Plasmídeo duplo de Nickase (h) | sc-402985-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DRβ5 Plasmídeo duplo de Nickase (h2) | sc-402985-NIC-2 | h | Gene Knockout | Puromycin | 0 |
HLA CRISPR Activation Products
HLA siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
Empty Table Header | Nome do Produto | CATALOG # | Species | Aplicacao | MARCADOR | Uso e aplicacao | NOTAS |
---|---|---|---|---|---|---|---|
HLA-A siRNA (h) | sc-42908 | h | Gene Silencing | N/A | 0 | ||
HLA-A Plasmídeo shRNA (h) | sc-42908-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-A sarna (h) Partículas de lentivirus | sc-42908-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-B siRNA (h) | sc-42922 | h | Gene Silencing | N/A | 0 | ||
HLA-B Plasmídeo shRNA (h) | sc-42922-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-B sarna (h) Partículas de lentivirus | sc-42922-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-C siRNA (h) | sc-105525 | h | Gene Silencing | N/A | 0 | ||
HLA-C Plasmídeo shRNA (h) | sc-105525-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-C sarna (h) Partículas de lentivirus | sc-105525-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DMα siRNA (h) | sc-42909 | h | Gene Silencing | N/A | 0 | ||
HLA-DMα Plasmídeo shRNA (h) | sc-42909-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DMα sarna (h) Partículas de lentivirus | sc-42909-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DMα siRNA (m) | sc-42910 | m | Gene Silencing | N/A | 0 | ||
HLA-DMα Plasmídeo shRNA (m) | sc-42910-SH | m | Gene Silencing | Puromycin | 0 | ||
HLA-DMα sarna (m) Partículas de lentivirus | sc-42910-V | m | Gene Silencing | Puromycin | 0 | ||
HLA-DM&beta Plasmídeo shRNA (m) | sc-42912-SH | m | Gene Silencing | Puromycin | 0 | ||
HLA-DM&beta sarna (m) Partículas de lentivirus | sc-42912-V | m | Gene Silencing | Puromycin | 0 | ||
HLA-DMβ siRNA (h) | sc-42911 | h | Gene Silencing | N/A | 0 | ||
HLA-DMβ Plasmídeo shRNA (h) | sc-42911-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DMβ sarna (h) Partículas de lentivirus | sc-42911-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DMβ siRNA (m) | sc-42912 | m | Gene Silencing | N/A | 0 | ||
HLA-DOα siRNA (h) | sc-95165 | h | Gene Silencing | N/A | 0 | ||
HLA-DOα Plasmídeo shRNA (h) | sc-95165-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DOα sarna (h) Partículas de lentivirus | sc-95165-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DOα siRNA (m) | sc-105526 | m | Gene Silencing | N/A | 0 | ||
HLA-DOα Plasmídeo shRNA (m) | sc-105526-SH | m | Gene Silencing | Puromycin | 0 | ||
HLA-DOα sarna (m) Partículas de lentivirus | sc-105526-V | m | Gene Silencing | Puromycin | 0 | ||
HLA-DOβ siRNA (h) | sc-42913 | h | Gene Silencing | N/A | 0 | ||
HLA-DOβ Plasmídeo shRNA (h) | sc-42913-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DOβ sarna (h) Partículas de lentivirus | sc-42913-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DOβ siRNA (m) | sc-42914 | m | Gene Silencing | N/A | 0 | ||
HLA-DOβ Plasmídeo shRNA (m) | sc-42914-SH | m | Gene Silencing | Puromycin | 0 | ||
HLA-DOβ sarna (m) Partículas de lentivirus | sc-42914-V | m | Gene Silencing | Puromycin | 0 | ||
HLA-DRα siRNA (h) | sc-37113 | h | Gene Silencing | N/A | 4 | ||
HLA-DRα Plasmídeo shRNA (h) | sc-37113-SH | h | Gene Silencing | Puromycin | 4 | ||
HLA-DRα sarna (h) Partículas de lentivirus | sc-37113-V | h | Gene Silencing | Puromycin | 4 | ||
HLA-DRα siRNA (m) | sc-37114 | m | Gene Silencing | N/A | 0 | ||
HLA-DRα Plasmídeo shRNA (m) | sc-37114-SH | m | Gene Silencing | Puromycin | 0 | ||
HLA-DRα sarna (m) Partículas de lentivirus | sc-37114-V | m | Gene Silencing | Puromycin | 0 | ||
HLA-E siRNA (h) | sc-62470 | h | Gene Silencing | N/A | 1 | ||
HLA-E Plasmídeo shRNA (h) | sc-62470-SH | h | Gene Silencing | Puromycin | 1 | ||
HLA-E sarna (h) Partículas de lentivirus | sc-62470-V | h | Gene Silencing | Puromycin | 1 | ||
HLA-E siRNA (m) | sc-62471 | m | Gene Silencing | N/A | 0 | ||
HLA-E Plasmídeo shRNA (m) | sc-62471-SH | m | Gene Silencing | Puromycin | 0 | ||
HLA-E sarna (m) Partículas de lentivirus | sc-62471-V | m | Gene Silencing | Puromycin | 0 | ||
HLA-F siRNA (h) | sc-105528 | h | Gene Silencing | N/A | 0 | ||
HLA-F Plasmídeo shRNA (h) | sc-105528-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-F sarna (h) Partículas de lentivirus | sc-105528-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-G siRNA (h) | sc-42920 | h | Gene Silencing | N/A | 2 | ||
HLA-G Plasmídeo shRNA (h) | sc-42920-SH | h | Gene Silencing | Puromycin | 2 | ||
HLA-G sarna (h) Partículas de lentivirus | sc-42920-V | h | Gene Silencing | Puromycin | 2 | ||
HLA-G siRNA (m) | sc-42921 | m | Gene Silencing | N/A | 0 | ||
HLA-G Plasmídeo shRNA (m) | sc-42921-SH | m | Gene Silencing | Puromycin | 0 | ||
HLA-G sarna (m) Partículas de lentivirus | sc-42921-V | m | Gene Silencing | Puromycin | 0 | ||
HLA-DP β1 siRNA (h) | sc-43929 | h | Gene Silencing | N/A | 0 | ||
HLA-DP β1 siRNA (h) | sc-42915 | h | Gene Silencing | N/A | 0 | ||
HLA-DP β1 Plasmídeo shRNA (h) | sc-42915-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DP β1 Plasmídeo shRNA (h) | sc-43929-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DP β1 sarna (h) Partículas de lentivirus | sc-42915-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DP β1 sarna (h) Partículas de lentivirus | sc-43929-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DPα1 siRNA (h) | sc-95353 | h | Gene Silencing | N/A | 0 | ||
HLA-DPα1 Plasmídeo shRNA (h) | sc-95353-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DPα1 sarna (h) Partículas de lentivirus | sc-95353-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DQA1 siRNA (h) | sc-105527 | h | Gene Silencing | N/A | 0 | ||
HLA-DQA1 Plasmídeo shRNA (h) | sc-105527-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DQA1 sarna (h) Partículas de lentivirus | sc-105527-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DQB1 siRNA (h) | sc-42918 | h | Gene Silencing | N/A | 0 | ||
HLA-DQB1 Plasmídeo shRNA (h) | sc-42918-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DQB1 sarna (h) Partículas de lentivirus | sc-42918-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-HB1 siRNA (h) | sc-91802 | h | Gene Silencing | N/A | 0 | ||
HLA-HB1 Plasmídeo shRNA (h) | sc-91802-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-HB1 sarna (h) Partículas de lentivirus | sc-91802-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DQA2 siRNA (h) | sc-42917 | h | Gene Silencing | N/A | 0 | ||
HLA-DQA2 Plasmídeo shRNA (h) | sc-42917-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DQA2 sarna (h) Partículas de lentivirus | sc-42917-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DRβ5 siRNA (h) | sc-72095 | h | Gene Silencing | N/A | 0 | ||
HLA-DRβ5 Plasmídeo shRNA (h) | sc-72095-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DRβ5 sarna (h) Partículas de lentivirus | sc-72095-V | h | Gene Silencing | Puromycin | 0 |
HLA Transfected Lysates
Empty Table Header | Nome do Produto | CATALOG # | Species | Anticorpo Controle | Uso e aplicacao | NOTAS |
---|---|---|---|---|---|---|
HLA-G (h2): 293T Lysate | sc-159524 | h2 | 0 |